BioMarin Pharmaceutical

Aktienkurs
58.13
Täglich Wechseln
0.98 1.71%
Monatlich
-5.19%
Jährlich
-9.07%
Q1 Prognose
56.35




Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Amgen USD 5.91B 2.31B 2025-09
Bayer EUR 1.51B 1.28B 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Gilead Sciences USD 4.03B 628M 2025-09
Incyte USD 581.52M 358.87M 2025-06
Insmed USD -297.13M 71.11M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 5.66B 3.77B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
United Therapeutics USD 436.8M 34.2M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


BioMarin Pharmaceutical - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.